These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28096287)

  • 21. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population.
    Coutinho AD; Lokhandwala T; Boggs RL; Dalal AA; Landsman-Blumberg PB; Priest J; Stempel DA
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1223-31. PubMed ID: 27354781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
    Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry.
    Kobayashi S; Hanagama M; Ishida M; Sato H; Ono M; Yamanda S; Yamada M; Aizawa H; Yanai M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3947-3955. PubMed ID: 30584294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbations of COPD.
    Pavord ID; Jones PW; Burgel PR; Rabe KF
    Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):21-30. PubMed ID: 26937187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
    Adibi A; Sin DD; Safari A; Johnson KM; Aaron SD; FitzGerald JM; Sadatsafavi M
    Lancet Respir Med; 2020 Oct; 8(10):1013-1021. PubMed ID: 32178776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.
    Cabrera C; Casanova C; Martín Y; Mirabal V; Sánchez Mdel C; Álvarez F; Juliá G; Cabrera-Navarro P; García-Bello MÁ; Marín JM; de-Torres JP; Divo M; Celli B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1217-22. PubMed ID: 27354780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
    Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COPD: it is time to change!
    Tantucci C; Pini L
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2451-7. PubMed ID: 26648707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist.
    Yang HH; Lai CC; Wang YH; Yang WC; Wang CY; Wang HC; Chen L; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2477-2485. PubMed ID: 28860742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.
    Duenk RG; Verhagen C; Bronkhorst EM; Djamin RS; Bosman GJ; Lammers E; Dekhuijzen P; Vissers K; Engels Y; Heijdra Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2121-2128. PubMed ID: 28790815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
    Devereux G; Cotton S; Barnes P; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; McCormack K; McPherson G; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Trials; 2015 Jun; 16():267. PubMed ID: 26058585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
    Singh D; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Lange P; Lettis S; Lipson DA; Mannino D; Martin N; Martinez FJ; Miller BE; Wise R; Zhu CQ; Lomas D
    Respir Res; 2021 Apr; 22(1):130. PubMed ID: 33910578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J; Karner C; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.
    Calverley PM; Tetzlaff K; Dusser D; Wise RA; Mueller A; Metzdorf N; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3391-3405. PubMed ID: 29238184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.
    Rennard SI; Calverley PM; Goehring UM; Bredenbröker D; Martinez FJ
    Respir Res; 2011 Jan; 12(1):18. PubMed ID: 21272339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.